Today, a total of 6 new shares were listed, including Jiarong technology, Zhongyi technology and Qingyan environment of gem, CNOOC on the main board of Shanghai Stock Exchange, Yaokang biology and nano core micro of sci-tech innovation board; Three new shares were listed, namely reed intelligence on GEM, Weijie Chuangxin and Haichuang pharmaceutical on Kechuang board.
subscription of new shares today
Jiarong technology is a leading high concentration wastewater treatment enterprise in China , focusing on the research and development of membrane technology. It is one of the few high concentration wastewater treatment service providers in China that can provide up to standard effluent and stable water volume. The company's performance grew rapidly, and the compound growth rate of revenue and net profit from 2018 to 2020 reached 41.36% and 31.33% respectively. Due to the addition of some fully quantitative processing projects with low gross profit margin and projects with great difficulty in processing, the company's comprehensive gross profit margin from 2018 to 2020 was 47.16%, 51.00% and 45.05% respectively.
Zhongyi science and technology has gradually accumulated and formed a number of core technologies related to the key processes of electrolytic copper foil industry , which runs through the whole production process of copper solution making, green foil, post-treatment and slitting. In terms of lithium copper foil, the company has gradually mastered 6 since 2017 μ M ultra thin lithium copper foil production technology and realize high-quality and large-scale production. At present, 6 μ M ultra thin lithium copper foil has become the mainstream product of lithium copper foil of the company. At the same time, the company actively expands the technological frontier and has mastered 4.5 μ M ultra thin lithium battery copper foil production technology is expected to become one of the company's main core products in the future.
Qingyan environment focuses on the field of rpir rapid biochemical sewage treatment , its rpir technology is initially studied and incubated by the Research Institute of Tsinghua University in Shenzhen, and the commercial application and promotion of rpir rapid biochemical sewage treatment technology is realized following the path of "theoretical model - technical equipment - process innovation". The company's market recognition and brand awareness have been continuously improved, and its products have been applied to water treatment projects in Shenzhen, Hubei, Jiangsu, Jiangxi, Guangxi, Henan, Shanxi, Sichuan and other places. From 2018 to 2020, the revenue reached 73 million yuan, 151 million yuan and 182 million yuan respectively, with a compound growth rate of 58.81% in recent three years. The company's comprehensive gross profit margin remained basically stable at a high level of about 60%.
CNOOC opened its subscription today. The company is the largest offshore crude oil and natural gas producer in China , and one of the largest independent oil and gas exploration and production groups in the world so far, China Petroleum & Chemical Corporation(600028) , Petrochina Company Limited(601857) and CNOOC will gather in A-Shares company is based in China and expands the world. Chinese assets are mainly located in four oil and gas bases in the Bohai Sea, the west of the South China Sea, the east of the South China Sea and the East China Sea, and overseas assets are distributed in six continents around the world.
By the end of 2020, the company has 239 oil and gas exploration rights in China's sea areas, covering an area of about 1.3 million square kilometers, accounting for more than 95% of the total number and area of exploration rights in China's sea areas , which has an absolute advantage. In terms of the scale of oil and gas resources, the company has a net proven reserves of about 5.37 billion barrels of oil equivalent at the end of 2020, and the service life of reserves has been maintained at more than 10 years in recent three years.
Yaokang biology is a leading enterprise in mouse model of experimental animals in China, with rich strain resource bank. By innovating gene editing technologies such as transgenic, ES targeting and CRISPR / cas9, the company has developed mouse strains with large customer demand, high degree of standardization and more practical use, such as immune deficiency mouse model, humanized mouse model and disease mouse model. As of June 30, 2021, the company's "spotted mouse program" resource library has about 19000 strains, and the number of strain resources is firmly in the forefront of the industry, covering genes in the research directions of tumor, metabolism, immunity, development, DNA and protein modification, realizing the product supply of Ko / CKO mouse model. According to Frost & Sullivan data, in 2019, the company's business revenue in China's experimental mouse products and services market was about 190 million yuan, accounting for 6.7% of the market, ranking second.
nano chip micro is a leading analog IC enterprise, which can provide a full range of digital isolation chip products and is at the leading level in China in the field of automotive electronic chips , with the rapid development of Pan new energy, there is a strong demand for isolation chips. The company's driving and sampling chips were shipped in batches in 2020q3, and the revenue in 2021 was 263691 million yuan, effectively becoming a new revenue growth point of the company. The company's products have achieved substantial growth in consumer electronics, electric energy storage, photovoltaic, power motor drive, new energy vehicles and other subdivided fields, and the sales of information sensing chips, isolation and interface chips have increased rapidly.
new shares listed today
As one of the pioneer enterprises in the intelligent controller industry of household appliances, Ruide intelligent has mastered a number of core technologies of intelligent controller. The main business is the R & D, production and sales of intelligent controllers, as well as the production and sales of a small number of terminal products. The main products include intelligent controllers of small household appliances such as kitchen appliances, household appliances and environmental appliances, and gradually penetrate and expand into the fields of household appliances, medical health, electric tools, smart home and so on the company has accumulated more high-quality customer resources, and has established long-term and stable cooperative relations with Zhejiang Supor Co.Ltd(002032) , Midea, chunmi, Emmett, Xinbao, Bear Electric Appliance Co.Ltd(002959) and other well-known manufacturers
Weijie Chuangxin's main business is the R & D, design and sales of RF front-end chips, and its main products are RF power amplifier modules. The company's products are widely used in mobile terminals such as smart phones, tablets and smart wearable devices, as well as communication devices such as wireless broadband routers. The downstream customers of company mainly include mainstream mobile phone brand manufacturers such as Xiaomi, oppo and vivo and well-known mobile terminal equipment ODM manufacturers such as Huaqin communication, Longqi technology, Wingtech Technology Co.Ltd(600745) and so on.
In addition, according to the prospectus of Weijie Chuangxin, its shareholder list covers Huawei, Hubble, oppo, Xiaomi, MediaTek and other enterprise giants of which, gaintech, the wholly-owned controlling entity of MediaTek, holds 28%, Hubble investment under Huawei holds 3.57%, oppo mobile holds 3.39% and Xiaomi fund holds 1.74%.
Haichuang pharmaceutical is a global innovative drug enterprise focusing on cancer and metabolic diseases. Since its establishment, the company has applied for more than 200 PCT and Chinese invention patents, and obtained more than 60 patents authorized by China, the United States, Japan, Europe and other countries and regions. now undertakes two major national science and technology projects of "major new drug creation" and several provincial and municipal scientific research projects
